Literature DB >> 1621416

Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison.

M Artois1, C Guittré, I Thomas, H Leblois, B Brochier, J Barrat.   

Abstract

Different oral vaccines intended to control fox rabies were administered to 271 wild rodents. Vaccines were administered orally or by the mucosal route to four different European species belonging to the genera Apodemus, Arvicola, Clethrionomys and Microtus. These rodents are likely to consume baits and to have contact with the vaccine. Two genetically engineered vaccines were tested: SAG1 (an avirulent mutant of the rabies virus) and V-RG (vaccinia recombinant virus expressing the rabies glycoprotein gene). Both were found to be completely innocuous when administered orally or by the mucosal route. The residual pathogenicity of conventional modified live vaccines derived from the SAD strain was confirmed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621416     DOI: 10.1016/0264-410x(92)90351-j

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Cross-protection of mice against a global spectrum of rabies virus variants.

Authors:  D L Lodmell; J S Smith; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

2.  A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.

Authors:  Zhenhai Chen; Ming Zhou; Xiudan Gao; Guoqing Zhang; Guiping Ren; Clement W Gnanadurai; Zhen F Fu; Biao He
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

3.  A recombinant rabies virus (ERAGS) for use in a bait vaccine for swine.

Authors:  Dong-Kun Yang; Ha-Hyun Kim; Sung-Suk Choi; Seong Heon Lee; In-Soo Cho
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

Review 4.  Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.

Authors:  Joanne Maki; Anne-Laure Guiot; Michel Aubert; Bernard Brochier; Florence Cliquet; Cathleen A Hanlon; Roni King; Ernest H Oertli; Charles E Rupprecht; Caroline Schumacher; Dennis Slate; Boris Yakobson; Anne Wohlers; Emily W Lankau
Journal:  Vet Res       Date:  2017-09-22       Impact factor: 3.683

5.  Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.

Authors:  Jennifer R Head; Ad Vos; Jesse Blanton; Thomas Müller; Richard Chipman; Emily G Pieracci; Julie Cleaton; Ryan Wallace
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

6.  Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.

Authors:  Conrad M Freuling; Verena Te Kamp; Antonia Klein; Maria Günther; Luca Zaeck; Madlin Potratz; Elisa Eggerbauer; Katharina Bobe; Christian Kaiser; Antje Kretzschmar; Steffen Ortmann; Peter Schuster; Adriaan Vos; Stefan Finke; Thomas Müller
Journal:  Viruses       Date:  2019-08-27       Impact factor: 5.048

Review 7.  Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.

Authors:  Philippe Mähl; Florence Cliquet; Anne-Laure Guiot; Enel Niin; Emma Fournials; Nathalie Saint-Jean; Michel Aubert; Charles E Rupprecht; Sylvie Gueguen
Journal:  Vet Res       Date:  2014-08-10       Impact factor: 3.683

8.  In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies.

Authors:  Steffen Ortmann; Antje Kretzschmar; Christiane Kaiser; Thomas Lindner; Conrad Freuling; Christian Kaiser; Peter Schuster; Thomas Mueller; Ad Vos
Journal:  Front Vet Sci       Date:  2018-05-18

Review 9.  Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination.

Authors:  Florence Cliquet; Anne-Laure Guiot; Michel Aubert; Emmanuelle Robardet; Charles E Rupprecht; François-Xavier Meslin
Journal:  Vet Res       Date:  2018-07-13       Impact factor: 3.683

Review 10.  Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms.

Authors:  A El-Sayed
Journal:  Int J Vet Sci Med       Date:  2018-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.